ARE · Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the second quarter ended June 30, 2026. KEY HIGHLIGHTS Operating results 2Q26 2Q25 1H26 1H25 Net (loss) income attributable to Alexandria's common stockholders – diluted: In millions $ (73.7) $ (109.6)

Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the first quarter ended March 31, 2026.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, April 28, 2026 at 2:00 p.m. Eastern Time (ET), in conjunction with the release of its first quarter 2026 operating and financial results. Alexandria will release its operating and financial results after the market closes on Monday, April 27, 2026. To participate in this conference call, dial (833) 366-1125 (U.S./Canada) or (412) 902-6738 (international) shortly before 2:00 p.m. ET and ask the operator to join the call for Alexandria Real Estate Equities, Inc. The live audio webcast can be accessed on the company's website at http://investor.are.com/webcasts . A replay of the call will be available from 4:00 p.m. ET on Tuesday, April 28, 2026 through 4:00 p.m. ET on Tuesday, May 5, 2026. To access the replay, dial (855) 669-9658 (U.S./Canada) or (412) 317-0088 (international) and enter access code 8933833.

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of $750,000,000 aggregate principal amount of 5.25% senior notes due 2036 (the "notes"). Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, BBVA Securities Inc., BMO Capital Markets Corp., BNP Paribas Securities Corp., Fifth Third Securities, Inc., Goldman Sachs & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC and Truist Securities, Inc. are acting as joint book-running managers in connection with the public offering, and Barclays Capital Inc., Capital One Securities, Inc., Huntington Securities, Inc., Mizuho Securities USA LLC, PNC Capital Markets LLC, Samuel A. Ramirez & Company, Inc., SMBC Nikko Securities America, Inc. and U.S. Bancorp Investments, Inc. are acting as co-managers in connection with the public offering. The notes were priced at

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing terms of its previously announced cash tender offers (the "Tender Offers") to purchase up to an aggregate principal amount of its outstanding 3.000% Senior Notes due 2051 (the "2051 Notes"), 3.550% Senior Notes due 2052 (the "2052 Notes") and 4.000% Senior Notes due 2050 (the "2050 Notes", and, together with the 2051 Notes and the 2052 Notes, the "Notes" and, each series, a "series of Notes"), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated January 27, 2026 (the "Offer to Purchase"), that will not result in an Aggregate Maximum Tender Amount (as defined in the Offer to Purchase) that exceeds $952,202,784.40, in order to accept all of the Notes that were validly tendered and not validly withdrawn at or prior to the Early Tender Date (as defined below). The Notes are fully and unconditionally guaranteed by Alexandria Real Estate

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public offering, subject to market conditions, of senior notes (the "notes"). Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Scotia Capital (USA) Inc. and TD Securities (USA) LLC will act as joint book-running managers in connection with the public offering. The notes will be unsecured obligations of the Company and fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P., an indirectly 100% owned subsidiary of the Company. The Company expects to use the net proceeds from this offering to repay a portion of the borrowings under the Company's commercial paper program incurred in connection with the repurchase or redemption of certain series of its outstanding senior unsecured notes (the "tender offer notes") pursuant to its previously announced cash tender offer (the "tender

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the results to date of its previously announced cash tender offers (the "Tender Offers") to purchase a portion of the Company's outstanding 3.000% Senior Notes due 2051 (the "2051 Notes"), 3.550% Senior Notes due 2052 (the "2052 Notes") and 4.000% Senior Notes due 2050 (the "2050 Notes", and, together with the 2051 Notes and the 2052 Notes, the "Notes" and, each series, a "series of Notes"), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated January 27, 2026 (the "Offer to Purchase"). The Notes are fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P. (the "Guarantor"). The Company also announced that it is increasing the Aggregate Maximum Tender Amount (as defined in the Offer to Purchase) in order to accept all of the Notes that were validly tendered and not validly withdrawn at or prior to the Early Tender Date (as

PASADENA, Calif. , Jan. 27, 2026 /PRNewswire/ - Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the commencement of cash tender offers ("Tender Offers") to purchase up to an aggregate principal amount that will not result in an aggregate purchase price that exceeds $800,000,000 (subject to increase or decrease by the Company, the "Aggregate Maximum Tender Amount") of its outstanding 3.000% Senior Notes due 2051 (the "2051 Notes"), 3.550% Senior Notes due 2052 (the "2052 Notes") and 4.000% Senior Notes due 2050 (the "2050 Notes", and, together with the 2051 Notes and the 2052 Notes, the "Notes" and, each series, a "series of Notes"), subject to the order of priority (the "Acceptance Priority Levels" as set forth in the table below under "Acceptance Priority Level"). The Notes are fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P. The price offered in the Tender Offers and other information relating

Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the fourth quarter and year ended December 31, 2025. Key highlights

Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced the tax treatment of its year 2025 distributions as described in the chart below. Stockholders are encouraged to consult with their own tax advisors as to their specific tax treatment of Alexandria Real Estate Equities, Inc. distributions. (1) Qualified and Section 199A dividends are a subset of, and included in, the taxable ordinary dividends amount. (2) For purposes of Section 1061 and Treasury Regulation §1.1061-6(c), the aggregate "One Year Amounts Disclosure" and "Three Year Amounts Disclosure" are $0.759679 (99.57% of Box 2a) per share and $0.622041 (81.53% of Box 2a) per share, respectively. Such additional information generally pertains to shares held through "applicable partnership interests" subject to Section 1061. (3) Unrecaptured Section 1250 gains are a subset of, and included in, the total capital gains amount. (4) These amounts reflect a distribution's composition of gains from the disposition of "United

PASADENA, Calif. , Jan. 5, 2026 /PRNewswire/ - Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured, and pioneering owner, operator, and developer of collaborative Megacampus ™ ecosystems in AAA life science innovation cluster locations, today celebrates the 32nd anniversary of the company's founding as a garage startup and its creation of life science real estate as a transformative new commercial asset class focused on the critically important life science industry — one that is vital to advancing U.S. health, economic resilience, and national security. The significant milestone reaffirms Alexandria's enduring leadership for over three decades at the vanguard of this essential industry, delivering mission-critical infrastructure and creating ecosystems that accelerate life science innovation to address the more than 90% of diseases that still lack effective treatments. "As the cornerstone of U.S. innovation and societal progress, the life science